journal
MENU ▼
Read by QxMD icon Read
search

Hepatobiliary & Pancreatic Diseases International: HBPD INT

journal
https://www.readbyqxmd.com/read/30001974/is-low-postoperative-cholesterol-level-really-an-independent-risk-factor-of-adverse-outcomes-after-living-donor-liver-transplantation
#1
LETTER
Qing Liu, Fu-Shan Xue, Gui-Zhen Yang, Ya-Yang Liu
No abstract text is available yet for this article.
May 24, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29866607/survivals-after-liver-transplantation-for-hepatocellular-carcinoma-granular-data-for-a-better-allocation-process
#2
LETTER
Quirino Lai, Massimo Rossi
No abstract text is available yet for this article.
May 24, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29866606/reply-to-is-low-postoperative-cholesterol-level-really-an-independent-risk-factor-of-adverse-outcomes-after-living-donor-liver-transplantation
#3
LETTER
Jian Yang, Wen-Tao Wang
No abstract text is available yet for this article.
May 24, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29861325/chimeric-antigen-receptor-engineered-t-cell-therapy-for-liver-cancer
#4
Yang Chen, Chang-Yong E, Zhi-Wen Gong, Shui Liu, Zhen-Xiao Wang, Yong-Sheng Yang, Xue-Wen Zhang
BACKGROUND: Chimeric antigen receptor-engineered T-cell (CAR-T) therapy is a newly developed immunotherapy used in the treatment of cancers. Because CAR-T therapy has shown great success in treating CD19-positive hematological malignancies, its application has been explored in the treatment of solid tumors, such as liver cancer. In this review, we discuss the immune characteristics of liver cancer, the obstacles encountered during the application of CAR-T therapy, and preclinical and clinical progress in the use of CAR-T therapy in patients with liver cancer...
May 24, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29805086/a-new-three-step-procedure-for-pancreatic-head-carcinoma-with-invasion-of-superior-mesenteric-artery
#5
EDITORIAL
Rui Tang, Jia-Hong Dong
No abstract text is available yet for this article.
May 18, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29709350/hepatic-fibrosis-it-is-time-to-go-with-hepatic-stellate-cell-specific-therapeutic-targets
#6
Devaraj Ezhilarasan, Etienne Sokal, Mustapha Najimi
Hepatic fibrosis is a pathological lesion, characterized by the progressive accumulation of extracellular matrix (ECM) in the perisinusoidal space and it is a major problem in chronic liver diseases. Phenotypic activation of hepatic stellate cells (HSC) plays a central role in the progression of hepatic fibrosis. Retardation of proliferation and clearance of activated HSCs from the injured liver is an appropriate therapeutic strategy for the resolution and treatment of hepatic fibrosis. Clearance of activated HSCs from the injured liver by autophagy inhibitors, proapoptotic agents and senescence inducers with the high affinity toward the activated HSCs may be the novel therapeutic strategy for the treatment of hepatic fibrosis in the near future...
April 21, 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29807766/lower-tacrolimus-trough-levels-in-the-late-period-after-living-donor-liver-transplantation-contribute-to-improvements-in-long-term-clinical-outcomes
#7
Lei Geng, Li-Dong Wang, Jun-Jie Huang, Tian Shen, Zhuo-Yi Wang, Bing-Yi Lin, Yu-Fu Ye, Shu-Sen Zheng
BACKGROUND: Previous studies have emphasized the need to reduce tacrolimus (TAC) trough levels in the early post-liver transplantation (LT) period. However, whether late-period TAC trough levels influence the long-term outcomes of liver recipients is not clear. METHODS: We enrolled 155 adult liver recipients survived more than 3 years after living donor liver transplantation because of non-malignant liver diseases. The maintenance immunosuppressive regimens were TAC monotherapy and combined therapy with mycophenolate mofetil...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29807765/laparoscopic-step-1-alpps-with-microwave-transection-of-the-liver-for-klatskin-tumors-is-it-worthwhile
#8
LETTER
Marcello Donati, Francesco Basile, Karl J Oldhafer
No abstract text is available yet for this article.
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29805087/hemobilia-due-to-hepatocellular-carcinoma-cholangioscopic-findings-and-novel-endoscopic-hemostasis
#9
LETTER
Takeshi Ogura, Atsushi Okuda, Kazuhide Higuchi
No abstract text is available yet for this article.
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29752133/usefulness-of-ca-19-9-for-pancreatic-cancer-screening-in-patients-with-new-onset-diabetes
#10
Jung Wan Choe, Hyo Jung Kim, Jae Seon Kim, Jaehyung Cha, Moon Kyung Joo, Beom Jae Lee, Jong-Jae Park, Young-Tae Bak
BACKGROUND: Generally, carbohydrate antigen 19-9 (CA 19-9) is not useful for screening pancreatic cancer in the asymptomatic general population. This study aimed to evaluate the utility of CA 19-9 level as a screening indicator of pancreatic cancer in asymptomatic patients with new-onset diabetes. METHODS: We retrospectively reviewed the medical records of patients who visited our health promotion center for health check-ups without cancer related symptoms from January 2005 to January 2014, and were newly diagnosed with diabetes mellitus (DM) within 2 years before their visit...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29748147/17-beta-hydroxysteroid-dehydrogenase-13-inhibits-the-progression-and-recurrence-of-hepatocellular-carcinoma
#11
Jun Chen, Jian-Yong Zhuo, Fan Yang, Zhi-Kun Liu, Lin Zhou, Hai-Yang Xie, Xiao Xu, Shu-Sen Zheng
BACKGROUND: Our previous study showed that 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) is down-regulated in hepatocellular carcinoma (HCC). But its function in HCC remains unknown. This study aimed to reveal the function of HSD17B13 and its clinical significance in HCC. METHODS: mRNA levels of HSD17B13 were analyzed in cohort 1 (30 normal, 30 HBV cirrhosis, 60 HBV-related HCC and 60 peritumoral tissue) by real-time PCR. HSD17B13 protein was evaluated in cohort 2 (15 normal, 33 HBV-cirrhosis, 12 dysplastic nodules, 34 HBV-related HCC, and 9 metastatic HCC) using immunohistochemistry...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29739648/prognostic-value-of-decision-criteria-for-emergency-liver-transplantation-in-patients-with-wild-mushroom-induced-acute-liver-injury
#12
Youn-Jung Kim, Hyung Joo Lee, Seung Mok Ryoo, Shin Ahn, Chang Hwan Sohn, Dong-Woo Seo, Kyoung Soo Lim, Won Young Kim
BACKGROUND: The reported mortality rate of mushroom-induced acute liver failure with conventional treatment is 1.4%-16.9%. Emergency liver transplantation may be indicated and can be the only curative treatment option. This study aimed to assess the prognostic value of criteria for emergency liver transplantation in predicting 28-day mortality in patients with mushroom-induced acute liver injury. METHODS: A retrospective cohort study was performed between January 2005 and December 2015...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29735301/apolipoprotein-a5-gene-polymorphisms-are-associated-with-non-alcoholic-fatty-liver-disease
#13
Yue Xu, Lin-Lin Lu, Shou-Sheng Liu, Shui-Xian Du, Hui-Ling Zhu, Quan-Jiang Dong, Yong-Ning Xin
BACKGROUND: Several studies have reported that apolipoprotein A5 (APOA5) is involved in the development of non-alcoholic fatty liver disease (NAFLD). However, no research has been performed regarding the association between APOA5 polymorphisms and the risk of NAFLD. This study aimed to explore the association between APOA5 gene polymorphisms and NAFLD in a Chinese Han population. METHODS: Genotypes of the SNPs (rs10750097, rs1263173, rs17120035, rs3135507 and rs662799) of APOA5 in 232 NAFLD patients and 188 healthy controls were determined using polymerase chain reaction (PCR) analysis...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29724676/a-pooled-analysis-of-treatment-and-prognosis-of-hepatic-angiosarcoma-in-adults
#14
De-Bang Li, Xiao-Ying Si, Tao Wan, Yan-Ming Zhou
BACKGROUND: Hepatic angiosarcoma is a rare malignant vascular tumor presenting unique treatment challenges. The aim of the present study was to determine the treatment and prognosis of this entity. DATA SOURCES: A systematic literature search was conducted using PubMed, Embase and Chinese Biomedical Literature database, to identify articles published from January 1980 to July 2017. Search terms were "hepatic angiosarcoma" and "liver angiosarcoma"...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29716791/predictors-of-30-day-readmission-following-pancreatic-surgery-a-retrospective-review
#15
Leo I Amodu, Jamil Alexis, Aron Soleiman, Meredith Akerman, Poppy Addison, Toni Iurcotta, Horacio L Rodriguez Rilo
BACKGROUND: Pancreatectomies have been identified as procedures with an increased risk of readmission. In surgical patients, readmissions within 30 days of discharge are usually procedure-related. We sought to determine predictors of 30-day readmission following pancreatic resections in a large healthcare system. METHODS: We retrospectively collected information from the records of 383 patients who underwent pancreatic resections from 2004-2013. To find the predictors of readmission in the 30 days after discharge, we performed a univariate screen of possible variables using the Fisher's exact test for categorical variables and the Mann-Whitney U test for continuous variables...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29627156/various-approaches-of-laparoscopic-common-bile-duct-exploration-plus-primary-duct-closure-for-choledocholithiasis-a-systematic-review-and-meta-analysis
#16
Ming-Yan He, Xia-Dong Zhou, Hao Chen, Peng Zheng, Fa-Zhan Zhang, Wei-Wei Ren
BACKGROUND: Common bile duct (CBD) stones may occur in up to 3%-14.7% of all patients with cholecystectomy. Various approaches of laparoscopic CBD exploration plus primary duct closure (PDC) are the most commonly used and the best methods to treat CBD stone. This systematic review was to compare the effectiveness and safety of the various approaches of laparoscopic CBD exploration plus PDC for choledocholithiasis. DATA SOURCES: Randomized controlled trials (RCTs) and non-randomized controlled trials (NRCTs) (case-control studies or cohort studies) were searched from Cochrane library (until Issue 2, 2015), Web of Science (1980-January 2016), PubMed (1966-January 2016), and Baidu search engine...
June 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29655663/announcements-for-this-section-should-be-submitted-in-the-correct-format-at-least-3-months-before-the-required-date-of-publication-this-list-is-provided-as-a-service-to-readers-inclusion-does-not-imply-endorsement-by-the-hepatobiliary-pancreatic-diseases-international
#17
https://www.readbyqxmd.com/read/29709219/bugbee-flexible-electrocautery-facilitates-choledochoscopic-biopsy-fulguration-and-debulking-of-a-high-grade-intraductal-papillary-neoplasm-of-the-bile-duct
#18
LETTER
Ravi N Srinivasa, Rajiv N Srinivasa, Joseph J Gemmete, Jeffrey Forris Beecham Chick
No abstract text is available yet for this article.
April 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29709218/clues-to-predict-incidental-gallbladder-cancer
#19
Naeem Goussous, Hadia Maqsood, Kalpesh Patel, Hamid Ferdosi, Naseem Muhammad, Anne M Sill, Gopal C Kowdley, Steven C Cunningham
BACKGROUND: Consequences of incidental gallbladder cancer (iGBC) following cholecystectomy may include repeat operation (depending on T stage) and worse survival (if bile spillage occurred), both avoidable if iGBC were suspected preoperatively. METHODS: A retrospective single-institution review was done. Ultrasound images for cases and controls were blindly reviewed by a radiologist. Chi-square and Student's t tests, as well as logistic regression and Kaplan-Meier analyses were used...
April 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29709217/glycogenic-hepatopathy
#20
Johad Khoury, Yaniv Zohar, Naim Shehadeh, Tarek Saadi
BACKGROUND: Glycogenic hepatopathy (GH) is a disorder associated with uncontrolled diabetes mellitus, most commonly type 1, expressed as right upper quadrant abdominal pain, hepatomegaly and increased liver enzymes. The diagnosis may be difficult, because laboratory and imaging tests are not pathognomonic. Although GH may be suggested based on clinical presentation and imaging studies, the gold standard for diagnosis is a liver biopsy, showing a significant accumulation of glycogen within the hepatocytes...
April 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
journal
journal
40247
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"